Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
102991000036116 | emtricitabine + rilpivirine + tenofovir (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
103001000036117 | tenofovir + emtricitabine + rilpivirine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
tenofovir + emtricitabine + rilpivirine | Is a | rilpivirine | false | Inferred relationship | Some | ||
tenofovir + emtricitabine + rilpivirine | has intended active ingredient | emtricitabine | false | Inferred relationship | Some | ||
tenofovir + emtricitabine + rilpivirine | has intended active ingredient | rilpivirine | false | Inferred relationship | Some | ||
tenofovir + emtricitabine + rilpivirine | has intended active ingredient | tenofovir | false | Inferred relationship | Some | ||
tenofovir + emtricitabine + rilpivirine | Is a | tenofovir + emtricitabine | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Is a | False | tenofovir + emtricitabine + rilpivirine | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set